Telehealthcare and Covid-19: A Noninvasive & Low Cost Invasive, Scalable
  and Multimodal Real-Time Smartphone Application for Early Diagnosis of
  SARS-CoV-2 Infection
  The global coronavirus pandemic overwhelmed many health care systems,
enforcing lockdown and encouraged work from home to control the spread of the
virus and prevent overrunning of hospitalized patients. This prompted a sharp
widespread use of telehealth to provide low-risk care for patients.
Nevertheless, a continuous mutation into new variants and widespread
unavailability of test kits, especially in developing countries, possess the
challenge to control future potential waves of infection. In this paper, we
propose a novel Smartphone application-based platform for early diagnosis of
possible Covid-19 infected patients. The application provides three modes of
diagnosis from possible symptoms, cough sound, and specific blood biomarkers.
When a user chooses a particular setting and provides the necessary
information, it sends the data to a trained machine learning (ML) model
deployed in a remote server using the internet. The ML algorithm then predicts
the possibility of contracting Covid-19 and sends the feedback to the user. The
entire procedure takes place in real-time. Our machine learning models can
identify Covid-19 patients with an accuracy of 100%, 95.65%, and 77.59% from
blood parameters, cough sound, and symptoms respectively. Moreover, the ML
sensitivity for blood and sound is 100%, which indicates correct identification
of Covid positive patients. This is significant in limiting the spread of the
virus. The multimodality offers multiplex diagnostic methods to better classify
possible infectees and together with the instantaneous nature of our technique,
demonstrates the power of telehealthcare as an easy and widespread low-cost
scalable diagnostic solution for future pandemics.
